Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
11/2012
11/01/2012US20120277180 Cofactors and Methods for Use for Individuals
11/01/2012US20120273770 Polycyclic ring-fused compound and organic thin film transistor utilizing same
11/01/2012CA2837434A1 Imidazole derivative
11/01/2012CA2834452A1 Derivatives of n- [( 1h - pyrazol - 1 - yl) aryl] - 1h - indole or 1h - indazole - 3 - carboxamide, their preparation and their use as p2y12 antagonists
11/01/2012CA2834166A1 Bicyclic pyridazine compounds as pim inhibitors
11/01/2012CA2833304A1 Salt of an inhibitor of phoshodiesterase 10 enzyme
11/01/2012CA2829171A1 Pyrazolidin-3-one derivatives
11/01/2012CA2826197A1 Pyrrolotriazinone derivatives as pi3k inhibitors
10/2012
10/31/2012EP2518073A1 Compounds for the treatment of Hepatitis C
10/31/2012EP2518072A1 Imidazopyridazine compounds
10/31/2012EP2518071A1 Imidazopyridine derivatives as PI3K inhibitors
10/31/2012EP2518070A1 Pyrrolotriazinone derivatives as PI3K inhibitors
10/31/2012EP2518067A1 Derivatives of N-[(1H-pyrazol-1-YL)aryl]-1H-indole or 1H- indazole-3-carboxamide and their therapeutic uses as P2Y12 antagonists
10/31/2012EP2518066A1 Novel anti-platelet agent
10/31/2012EP2516443A2 Methods for the purification of cucurbituril
10/31/2012EP2516442A1 Pyrrolo[2,3-d]pyrazin-7-yl pyrimidine compounds
10/31/2012EP2516440A1 Bridgehead amine ring -fused indoles and indolines useful to treat neurodegenerative and neuropsychiatry disorders
10/31/2012EP2516434A1 Fused heteroaromatic pyrrolidinones as syk inhibitors
10/31/2012EP2516425A1 Aminopyrimidine kinase inhibitors
10/31/2012EP2516008A1 Novel antiviral compounds
10/31/2012EP2515648A1 Methods for the synthesis of polycyclic guanidine compounds
10/31/2012CN102762570A Pyrazole derivatives as JAK inhibitors
10/31/2012CN102762569A Benzodiazepine bromodomain inhibitor
10/31/2012CN102762561A Gamma secretase modulaters
10/31/2012CN102762556A Imidazo[1,2-a] pyridine compounds, synthesis thereof, and methods of using same
10/31/2012CN102762546A Materials for organic light emitting devices
10/31/2012CN102757439A Natural cobalt iron chlorophyllin and preparation method thereof
10/31/2012CN102757438A Natural nickel ferrous chlorophyll salt and preparation method thereof
10/31/2012CN102757437A Phthalocyanine nano-rod array film and preparation method and application thereof
10/31/2012CN102757436A Method for preparing sodium copper chlorophyllin and alkaloids from mugwort leaf as raw material
10/31/2012CN102757435A Trans-3-indolyl-4-pyrroldiazepinecycloheptane-2,5-pyrrolidine-2,5-diketone compound and preparation method thereof
10/31/2012CN102757434A Preparation method for industrial amplified production of anagrelide hydrochloride active pharmaceutical ingredient
10/31/2012CN102757433A Synthesis of lactic bicyclic guanidine and technique for catalyzing ring-opening polymerization synthesis of degradable polymers by using lactic bicyclic guanidine
10/31/2012CN102757432A Synthesis of glycollic bicyclic guanidine and technique for catalyzing ring-opening polymerization synthesis of degradable polymers by using glycollic bicyclic guanidine
10/31/2012CN102757431A Novel method for synthesizing sitagliptin
10/31/2012CN102757422A Derivatives of N-[(1H-pyrazol-1-yl)aryl]-1H-indole or 1H- indazole-3-carboxamide and their therapeutic uses as p2y12 antagonists
10/31/2012CN102757386A Peptide derivative and pharmaceutical composition and application thereof
10/31/2012CN101980711B Aromatic heterocyclic fused indolobenzadiazepine HCV NS5B inhibitors
10/30/2012US8299247 Material for organic electroluminescence device and organic electroluminescence device
10/30/2012US8299240 Method of producing a metal phthalocyanine compound, and method of producing a phthalocyanine compound and an analogue thereof
10/30/2012US8299084 Piperidine inhibitors of Janus kinase 3
10/30/2012US8299076 Crystalline forms of 2-(2-flouro-4-iodophenylamino)-N-(2-hydroxyethoxy)-1,5-dimethyl-6-oxo-1,6-dihydropyridine-3-carboxamide
10/30/2012US8299064 Fused polycyclic compounds having a heterocyclic ring(s) and pharmaceutical use thereof
10/30/2012US8299058 Spiro-condensed indoline derivatives as pesticides
10/30/2012US8298512 Methods of determining β-III tubulin expression
10/30/2012CA2683318C Diazo bicyclic smac mimetics and the uses thereof
10/30/2012CA2568592C Alkyl substituted indoloquinoxalines
10/30/2012CA2548156C Amine derivatives
10/26/2012WO2012145581A1 Disubstituted octahy-dropyrrolo [3,4-c] pyrroles as orexin receptor modulators
10/26/2012WO2012143599A1 Androgen receptor modulating carboxamides
10/26/2012WO2012143522A1 Tetrahydropyrazolo [1,5 -a] pyrimidine as anti -tuberculosis compounds
10/26/2012WO2012143510A1 Fluoroalkyl-substituted pyrazolopyridines and use thereof
10/26/2012WO2012143320A1 (7h-pyrrolo[2,3-d]pyrimidin-2-yl)amine compounds as jak3 inhibitors
10/26/2012WO2012143144A1 Pyrazolo [4, 3-d] pyrimidines useful as kinase inhibitors
10/26/2012WO2011113606A8 Anti-infective compounds
10/26/2012CA2833698A1 Fluoroalkyl-substituted pyrazolopyridines and use thereof
10/26/2012CA2831634A1 Pyrazolo [4,3-d] pyrimidines useful as kinase inhibitors
10/26/2012CA2831338A1 Androgen receptor modulating carboxamides
10/25/2012US20120271048 Novel 1,6-disubstituted indole compounds as protein kinase inhibitors
10/25/2012US20120271045 Methods for preparing pyrimidine derivatives useful as protein kinase inhibitors
10/25/2012US20120270880 Pyrrolo [2,3-d] pyrazin-7-ylpyrimidine compounds
10/25/2012US20120270879 Heterocyclic Compounds As CCR1 Receptor Antagonists
10/25/2012US20120270857 5-ht3 receptor modulators, methods of making, and use thereof
10/25/2012US20120270838 Spiroimidazolone derivative
10/25/2012US20120270141 Nitrogen-containing aromatic compounds and metal complexes
10/25/2012US20120267583 Stable free radical chromophores, processes for preparing the same, nonlinear optic materials and uses thereof in nonlinear optical applications
10/25/2012DE102011007891A1 New ring-fused 4-aminopyrimidine compounds are guanylate cyclase stimulators useful to treat and/or prevent e.g. heart failure, angina pectoris, hypertonia, pulmonary hypertonia, ischemia, vascular disease and renal insufficiency
10/25/2012DE102011007890A1 New fluoroalkyl-substituted pyrazolopyridine compounds are soluble guanylate cyclase stimulators, useful to treat e.g. heart disease, angina pectoris, hypertension, pulmonary hypertension, ischemia, vascular disease or renal insufficiency
10/24/2012EP2513114A1 Pyrrolo[2,3-d]pyrimidine compounds
10/24/2012EP2513113A1 5,5-fused arylene or heteroarylene hepatitis c virus inhibitors
10/24/2012EP2513107A1 Heteroaromatic phenylimidazole derivatives as pde10a enzyme inhibitors
10/24/2012EP2513105A1 2-arylimidazole derivatives as pde10a enzyme inhibitors
10/24/2012EP2513102A1 Ethynyl derivatives
10/24/2012EP2513096A1 Substituted aminothiazolone indazoles as estrogen related receptor-a modulators
10/24/2012EP2513090A1 Compound suitable for the treatment of synucleopathies
10/24/2012EP2513064A2 Compounds, compositions and methods for controlling biofilms
10/24/2012EP2513059A1 Inhibitors of akt activity
10/24/2012EP2512246A1 Aminopyrimidines as syk inhibitors
10/24/2012CN102754238A 有机电致发光元件 Organic electroluminescent element
10/24/2012CN102754237A 有机电致发光元件 Organic electroluminescent element
10/24/2012CN102753555A Macrocycles as factor XIA inhibitors
10/24/2012CN102753554A Raf inhibitor compounds and methods of use thereof
10/24/2012CN102753551A 2-arylimidazole derivatives as pde10a enzyme inhibitors
10/24/2012CN102753548A Fused heteroaromatic pyrrolidinones
10/24/2012CN102753544A 1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties
10/24/2012CN102753525A Process for preparing 3-[(4s)-8-bromo-1-methyl-6-(2-pyridinyl)-4h-imidazol[1,2-a][1,4]benzodiazepine-4-yl]propionic acid methyl ester or the benzene sulfonate salt thereof, and compounds useful in that process
10/24/2012CN102746311A Natural strontium ferrous chlorophyllin and preparation method thereof
10/24/2012CN102746310A Method for producing industrial urotropine through taking waste paraformaldehyde as raw material
10/24/2012CN102746309A 1-N-ethyl-4-N-2'-substituted acylhydrazine-1H-pyrazol [3, 4-d] miazines derivative as well as preparation method and application thereof
10/24/2012CN102746308A Allopurinol derivative and preparation method and application thereof
10/24/2012CN102746307A 1-N-benzyl allopurinol derivative as well as preparation method and application thereof
10/24/2012CN102746306A Allopurinol derivative and preparation method and application thereof
10/24/2012CN102746305A Inhibitors of bruton's tyrosine kinase
10/24/2012CN101567425B Organic electroluminescence device, novel platinum complex compound and novel compound capable of being a ligand thereof
10/24/2012CN101535311B Salts of pyrrolopyrimidinone derivatives and process for preparing the same
10/24/2012CN101456862B Phenylguanidine derivates containing pyrazolo pyrimidinone, medicament composition thereof as well as preparation method and application thereof
10/24/2012CN101417998B Purification method of pemetrexed salt
10/24/2012CN101374844B Pyrrolopyridazinone compound
10/24/2012CN101282930B Fab I inhibitor and process for preparing same
10/24/2012CN101239943B Method for producing phthalocyanine compound and its intermediate, and intermediate compound for the same
1 ... 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 ... 573